NATIONAL
CANCER
INSTITUTE

NCI Cancer Bulletin
A Trusted Source for Cancer Research News
September 26, 2006 • Volume 3 / Number 37 E-Mail This Document  |  Download PDF  |  Bulletin Archive/Search  |  Subscribe


Bulletin Home

Featured Article
Tanning Study Suggests Strategies for Preventing Skin Cancer

Director's Update
Workshop Helps RAID Program Adapt, Evolve

Cancer Research Highlights
Common Prostate Cancer Treatment May Increase Diabetes Risk

Gemcitabine Plus Carboplatin Benefits Women with Recurrent Ovarian Cancer

Advanced Cancer Patients Benefit More from Aromatase Inhibitors than Tamoxifen

Rising Kidney Cancer Mortality Challenges Treatment Standards

Age Associated with Type of Breast Cancer Treatment

Spotlight
Answers, and More Questions, Emerging on Pediatric Leukemia

Featured Clinical Trial
Combining Targeted Therapies for Thoracic Cancers

Notes
NCI Director's Awards Ceremony Scheduled in October

Save the Date for AIDS Malignancy Program Conference

FARE 2007 Winners Are Awarded

SBIR Program Announces New Contract Funding Opportunities

Community Update
NCI Cooperative Groups Celebrate 50th Anniversary on Capitol Hill

Bulletin Archive

About the Bulletin

Page Options
Print This Page
Print This Document
View Entire Document
E-Mail This Document
View/Print PDF
Notes

NCI Director's Awards Ceremony Scheduled in October
The NCI Director's Awards ceremony will honor NCI staff for their outstanding contributions over the past year on October 25 at 11:00 a.m. in the Natcher Auditorium on the NIH campus. A reception will follow in the Natcher Atrium.

Awardees will be announced in the following categories: NIH merit (group and individual); leading diversity (group and individual); length of service (30 and 40 years); outstanding mentor; mentors of merit; and Commissioned Corps' Public Health Service citation, outstanding service medal, and commendation medal.

The ceremony will be videocast at http://videocast.nih.gov.

Save the Date for AIDS Malignancy Program Conference
The International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies - supported by NCI's Office of AIDS Malignancy Program and the Office of International Affairs, with help from the NCI Office of Women's Health - will be held October 16-17 at the Bethesda North Marriott Conference Center in Bethesda, Md.

The conference will bring together scientists, physicians, health care workers, and community and patient advocates to focus on the viral oncology, immunology, genetics, epidemiology, pathogenesis, early diagnosis, and clinical investigation of malignant diseases associated with AIDS and other acquired immune-deficiency states. The event's objective is to facilitate the exchange of information between laboratory and clinical researchers to accelerate the translation of basic scientific discoveries into clinical applications.

The conference is free, but registration is required by October 9. For more information, go to http://www.palladianpartners.com/aidsmalignancy/index.htm.

FARE 2007 Winners Are Awarded
The Fellows Award for Research Excellence (FARE) Poster and Awards Day was held September 25 in the Lipsett Amphitheater at NIH. Following the ceremony, FARE winners presented their abstracts in a poster section.

The annual NIH-wide FARE competition - sponsored by the NIH Fellows Committee, the Scientific Directors, the NIH Office of Research on Women's Health, and the NIH Office of Intramural Training and Education - provides recognition for outstanding scientific research performed by intramural postdoctoral fellows.

This year's FARE awardees include 91 fellows from NCI's CCR, Division of Cancer Control and Population Sciences, Division of Cancer Epidemiology and Genetics, and DCP. They also receive a certificate and $1,000 in support to attend a scientific conference of their choice, and are asked to serve as judges for the following year's competition.

To apply, each April, fellows submit abstracts of their research, which are then peer reviewed by a jury of scientists whose work received awards in previous years. Visit http://felcom.nih.gov/FARE for more details.

SBIR Program Announces New Contract Funding Opportunities
On August 8, NCI's Small Business Innovation Research (SBIR) program announced 13 new funding opportunities for small businesses in a range of novel technology areas. Funding is available to support research and development of anticancer agents, biomarkers, nanotechnology, proteomics, pharmacodynamics, and other areas. The deadline for receipt of proposals is November 6. Additional information about the new contract funding opportunities and applicant eligibility is available at http://sbir.cancer.gov/funding/contracts/ or by e-mailing ncisbir@mail.nih.gov.

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov